NATERA, INC. Retained Earnings
NATERA, INC. (NTRA) had Retained Earnings of -$2.93 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$2.93B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$2.86B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.78B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.82B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$2.93B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | -$2.86B 10-Q · filed 2026-05-08 | |
| 2025-12-31 | -$2.78B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | -$2.82B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | -$2.74B 10-Q · filed 2025-08-08 | |
| 2025-03-31 | -$2.63B 10-Q · filed 2025-05-09 | |
| 2024-12-31 | -$2.57B 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$2.51B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$2.48B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | -$2.45B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | -$2.38B 10-K · filed 2025-02-28 | |
| 2023-09-30 | -$2.30B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$2.19B 10-Q · filed 2023-08-04 | |
| 2023-03-31 | -$2.08B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$1.94B 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$1.80B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | -$1.68B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | -$1.53B 10-Q · filed 2022-05-06 | |
| 2021-12-31 | -$1.39B 10-K · filed 2023-03-01 | |
| 2021-09-30 | -$1.25B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | -$1.10B 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$986.97M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | -$929.32M 10-K · filed 2022-02-25 | |
| 2020-09-30 | -$852.91M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$794.58M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$734.95M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$699.17M 10-K · filed 2021-02-26 | |
| 2019-09-30 | -$663.99M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$640.85M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$699.20M 10-Q · filed 2020-05-08 | -$608.43M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$574.53M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$542.69M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$513.07M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$479.25M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$446.38M 10-K · filed 2019-03-15 | -$482.16M 10-K · filed 2018-03-15 |
| 2017-09-30 | -$436.66M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$409.54M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$381.81M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$345.85M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$307.94M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$281.92M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | -$258.77M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$250.08M 10-K · filed 2017-03-16 | |
| 2015-09-30 | -$227.12M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$209.49M 10-Q · filed 2015-08-13 | |
| 2014-12-31 | -$179.81M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |